Klotho Neurosciences Inc - רווח החברה לפני מסים, ריבית ופחת KLTO

Klotho Neurosciences Inc (KLTO) relies on the high scalability of intellectual capital within the field of CNS anti-aging. Operating cash flow before depreciation clearly demonstrates cash flow dynamics, where the 0.00 level records fresh values. A breakthrough R&D pipeline for the treatment of Alzheimer's and ALS complements the image of a scientific brand that is actively implementing innovations in gerontology and brain health.
פילוחי נתונים אנליטיים מרוכזים עבור Klotho Neurosciences (KLTO)

For Klotho Neurosciences Inc (KLTO), whose operations are limited to laboratory research without industrial production, EBITDA serves as an indicator of actual cash flow. This metric excludes GAAP accounting adjustments to calculate the net volume of operating cash, allowing investors to objectively assess capital financial stability and avoid purchasing an overvalued asset at an early stage of development.